共 77 条
[1]
Ferrannini E(2012)Diabetes and hypertension: the bad companions Lancet 380 601-10
[2]
Cushman WC(1993)Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the multiple risk factor intervention trial. Diabetes Care 16 434-44
[3]
Stamler J(2000)Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study BMJ 321 412-93
[4]
Vaccaro O(2005)Independent and additive impact of blood pressure control and angiotensin II receptor blockade on renal outcomes in the irbesartan diabetic nephropathy trial: clinical implications and limitations J Am Soc Nephrol 16 3027-37
[5]
Neaton JD(2007)Guidelines for the management of arterial hypertension. The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) Eur Heart J 28 1462-536
[6]
Wentworth D.(2011)Long-term and recent progress in blood pressure levels among U.S. adults with diagnosed diabetes, 1988–2008 Diabetes Care 34 1579-81
[7]
Adler AI(2009)Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document J Hypertens 27 2121-58
[8]
Stratton IM(2011)Blood pressure control in diabetes mellitus: is lower always better, and how low should it go Circulation 123 2776-8
[9]
Neil HA(2012)Evidence-based hypertension treatment in patients with diabetes J Clin Hypertens 14 97-102
[10]
Pohl MA(2012)Pros and cons of aggressive blood pressure lowering in patients with type 2 diabetes Curr Vasc Pharmacol 10 156-61